Robert Duggan (Kelly Morfopoulos via Wikimedia)
With Covid-19 mucking the tires, Robert Duggan throws another $50M behind his big antibiotics play
Robert Duggan is upping his ante on Summit Therapeutics.
The billionaire investor quietly bid up to 65% of the small antibiotic developer before
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
